Analytik Jena Opens Swiss Branch Office at the Endress+Hauser Headquarters
Analytik Jena AG has established a branch office on the premises of Endress+Hauser at the Reinach site near Basel in Switzerland.
“This step is part of our strategy to further expand our international sales structure and to establish our own organization and direct sales wherever tangible growth potential is recognized,” says Klaus Berka, CEO of Analytik Jena AG. “We are growing internationally and, with our own structures, can better address the requirements of our customers around the world.”
“The Analytik Jena branch office helps us to pursue our aim of supporting customers from the lab into the rest of the process,” explains Dirk Neirinck, Managing Director of Endress+Hauser Consult AG. The Swiss sales company of the specialist in measurement and automation technology is located inside the same building.
With the new branch office, Analytik Jena will initially ensure direct service and supply for Analytical Instrumentation customers in the Swiss market. The chemical-pharmaceutical sector, which along with mechanical engineering is among the most important industrial sectors in Switzerland, offers much growth potential for Analytik Jena. “We intend to expand direct sales in our largest business unit and strengthen our market presence. We are also opening up the opportunity to break into new regions and, through local support, generate market shares particularly in the French-speaking region of Switzerland. As a result, we will be much closer to the customer,” says Berka.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Antibiotics could be alternative to surgery as treatment for appendicitis
Diabetes drug found no better than placebo at treating NAFLD
Karo Bio Announces Successful Phase II Study with Eprotirome in Combination with Statin
Camouflage mechanism of cancer cells in Hodgkin's lymphoma decoded - Curt Meyer Memorial Prize for Dr. Stephan Mathas and Dr. Martin Janz
Phase 2a Study of HIV-1 Investigational Maturation Inhibitor - Demonstration of positive results for therapy designed to attack virus in a new way
Amarna Therapeutics Teaming Up with Austrian CBmed in the Development of Immunotherapies
Merck Announces Future Insight Prize for Groundbreaking Scientific Work - Prize money up to 1 million Euro
Astellas and UCB announce approval of Cimzia in Japan for the treatment of rheumatoid arthritis
Biovitrum strengthens its relationship with Wyeth - Starts to co-promote BeneFIX in the Nordic countries
PET imaging detects fast-growing prostate cancer
BASF acquires global leader in omega-3 fatty acids
